Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Montana. Pick another state for the same tag.
Against expectation — 2025
Montana cites F756 less often than its own record predicts
Versus expected share0.79×
0.79 times the national share — cited less often here than elsewhere.
Share of Montana citations0.63%
Of every deficiency written in Montana in 2025, this is the portion that was F756.
Montana0.63%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F756 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJune 18, 2026
Based on interview and record review, the facility failed to ensure all the irregularities noted by the pharmacist on the monthly medication regimen review were addressed and documented in the resident's medical record for 2 (#s 5 and 13) of 15 sampled residents. Findings include:1. Review of the [Pharmacy Name] Monthly Consulting document, dated February of 2026, showed the following nursing recommendation for resident #5, [Resident #5] needs an AIMS assessment due to Seroquel use.Review of resident #5's Assessments section of the EHR, dated between 1/1/26 and 6/15/26, showed one AIMS assessment was completed on 5/18/26. No other AIMS assessments were completed during that time.2. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction